DDX57 activators are broadly categorized into molecules that modulate cellular energy levels, transcriptional and translational stress, and protein folding homeostasis. ATP provides the energy required for the helicase activity of DDX57, making it a fundamental activator for the protein's function. Compounds like leptomycin B and actinomycin D alter nuclear RNA levels and transcriptional processes, potentially increasing dependency on RNA helicases for management and processing of RNA molecules. Inhibitors like A-443654, 5-Azacytidine, and LY294002 impact various signaling cascades and epigenetic states, which may lead to a compensatory rise in DDX57 activity due to altered RNA metabolism requirements. Hsp90 inhibitors such as 17-AAG and geldanamycin can induce stress responses, which may upregulate proteins like DDX57 as a protective mechanism.
Additionally, agents such as cycloheximide and MG132 interfere with protein synthesis and degradation, respectively, which can enhance the cellular need for RNA processing, potentially driving the function of RNA helicases like DDX57. By influencing cellular energy pathways, 2-Deoxy-D-glucose can lead to a scenario where the energy management system of the cell becomes compromised, possibly requiring DDX57 activity to maintain cellular homeostasis. Staurosporine's broad kinase inhibition can result in a multifaceted stress response that includes the upregulation of RNA processing activities.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
Direct energy source for DEAD-box proteins, required for the RNA helicase activity of DDX57. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibitor of nuclear export, increasing nuclear retention of RNA, potentially requiring DDX57 activity. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and prevents transcription, potentially increasing reliance on DDX57 for RNA processing of existing transcripts. | ||||||
A-443654 | 552325-16-3 | sc-507339 | 1 mg | $140.00 | ||
Akt inhibitor that may lead to compensatory effects in RNA processing and metabolism, potentially enhancing DDX57 activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that causes DNA demethylation, affecting gene expression profiles, including genes related to RNA metabolism which may activate DDX57. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Hsp90 inhibitor, which may destabilize client proteins and lead to increased demand for RNA helicase activities of DDX57. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis, possibly leading to an increased requirement for DDX57 in RNA surveillance and processing mechanisms. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can lead to increased stress on RNA metabolism and potentially a greater role for DDX57 in managing misfolded proteins' RNA transcripts. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of PI3K which could affect various signaling pathways, indirectly necessitating enhanced DDX57 activity in RNA processing. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glycolysis inhibitor that can lead to energy stress and potentially increase demand for DDX57 activity as part of the stress response. | ||||||